Immunic (IMUX) Stock Insights

IMUX price $7.98 +0.37 +4.86%

Ticker
IMUX
Price
$7.98
Change
+0.37 +4.86%
Market cap ?
$108.88M
P/E ?
-1.54
Forward P/E ?
5.28
Dividend yield ?
0.00%
Beta ?
1.45
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
6315.12000000000

Immunic, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective oral immunotherapies for a range of chronic inflammatory and autoimmune conditions. Its primary investigational compound, IMU-838, has advanced to Phase 2 clinical trials, targeting relapsing-remitting multiple sclerosis (RRMS), inflammatory bowel disease (IBD), various other chronic inflammatory…

Fair value

IMUX fair value $19.88. Price $7.98. Price is 60% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 353. Growth 8.36%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.5). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 13.64M. Net debt -14.80M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare IMUX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.93——
2026-08-11-0.80-1.16——
2026-05-13-1.08-0.71——
2026-02-26-1.20-0.90——
2025-11-13-1.30-0.18——
2025-08-07-2.00-1.58——
2025-05-15-2.50-2.50——
2025-04-03-2.50-0.22—6.00K
2024-11-07-2.40-2.20—6.00K
2024-08-08-2.10-0.23—10.00K
2024-05-09-2.50-0.27——
2024-02-22-4.80-0.51——
2023-11-14-5.10-0.55——
2023-08-03-5.40-0.53——
2023-05-11-5.80-0.52——
2023-02-23-16.30-0.82——
2022-11-03-6.90-0.67——
2022-08-04-7.20-0.73——
2022-05-10-7.40-0.81——
2022-02-24-8.04-0.77——
2021-11-04-7.60-8.10——
2021-08-06-8.20-7.20——
2021-05-06-16.30-6.90——
2021-02-26-4.60-5.90——
2020-11-05-7.00-6.10——
2020-08-02-9.00-6.20——
2020-05-08-7.90-9.60——
2020-03-16-5.60-0.76——
2019-11-07-8.20-0.67——
2019-08-08-15.20-0.68——
2019-04-10-88.00———
2019-03-04-56.82———
2018-11-07-11.20-11.20——
2018-08-07-12.00-13.20——
2018-05-08-13.60-13.60——
2018-03-13-14.00-12.40——
2017-10-25-12.00-12.80——
2017-08-03-11.60-14.13——
2017-05-09-15.60-14.60——
2017-03-07-14.80-14.20——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-16Nagel Robert ThorvaldBuy25.37K$10.12256.74K
2026-09-16BVF PARTNERS L P/ILBuy25.37K$10.12256.74K
2026-08-06Ridloff ElenaBuy50.74K$14.54737.76K
2026-08-06Ridloff ElenaOther0——
2026-07-05Skerjanec SimonaBuy25.37K$14.80375.48K
2026-07-05Rudick Richard AlanBuy25.37K$14.80375.48K
2026-07-05PHILLIPS BARCLAY ABuy25.37K$14.80375.48K
2026-07-05Neermann JoergBuy25.37K$14.80375.48K
2026-07-05Congleton JonBuy25.37K$14.80375.48K
2026-06-29Congleton JonBuy50.74K$10.90553.07K
2026-06-29Skerjanec SimonaBuy25.37K$10.90276.53K
2026-06-29Rudick Richard AlanBuy25.37K$10.90276.53K
2026-06-29HOWSON TAMAR DBuy25.37K$10.90276.53K
2026-06-29Neermann JoergBuy25.37K$10.90276.53K
2026-06-29PHILLIPS BARCLAY ABuy25.37K$10.90276.53K
2026-06-29Tardio JasonBuy253.00K$11.602.93M
2026-06-29Whaley GlennBuy120.00K$11.601.39M
2026-06-29Vitt DanielBuy445.00K$11.605.16M
2026-06-29BONNEY MICHAEL WBuy100.00K$12.081.21M
2026-06-01Lundgren ErikOther0——
2026-05-22Lundgren ErikBuy1.00M$13.0513.05M
2026-05-16BONNEY MICHAEL WOther0——
2026-04-24Panzara Michael A.Buy300.00K$8.802.64M
2026-04-24Panzara Michael A.Other0——
2026-03-27Congleton JonOther0——
2026-02-17BVF PARTNERS L P/ILOther0——
2026-02-17BVF PARTNERS L P/ILOther0——
2026-02-17BVF PARTNERS L P/ILOther0——
2026-02-17BVF PARTNERS L P/ILOther3.20M——
2026-02-17BVF PARTNERS L P/ILOther3.20M——
2026-02-17Nagel Robert ThorvaldOther0——
2025-07-16Whaley GlennBuy560.00K$0.77431.20K
2025-07-16Whaley GlennBuy280.00K$0.77215.60K
2025-07-16Nash DuaneBuy630.00K$0.77485.10K
2025-07-16Nash DuaneBuy315.00K$0.77242.55K
2025-07-16Vitt DanielBuy1.72M$0.771.32M
2025-07-16Vitt DanielBuy860.00K$0.77662.20K
2025-07-16Muehler AndreasBuy660.00K$0.77508.20K
2025-07-16Muehler AndreasBuy330.00K$0.77254.10K
2025-07-16Tardio JasonBuy660.00K$0.77508.20K
2025-07-16Tardio JasonBuy330.00K$0.77254.10K
2025-06-13Nash DuaneBuy20.00K$0.8316.69K
2025-06-05Tardio JasonBuy598.50K$0.77462.58K
2025-06-05Whaley GlennBuy503.50K$0.77389.16K
2025-06-05Vitt DanielBuy1.56M$0.771.20M
2025-06-05Nash DuaneBuy570.00K$0.77440.55K
2025-06-05Muehler AndreasBuy598.50K$0.77462.58K
2025-06-05HOWSON TAMAR DBuy150.00K$0.77115.94K
2025-06-05Skerjanec SimonaBuy150.00K$0.77115.94K
2025-06-05Rudick Richard AlanBuy150.00K$0.77115.94K
2025-06-05Toernsen Monika MariaBuy150.00K$0.77115.94K
2025-06-05Tardio JasonBuy595.00K$0.77459.88K
2025-06-05Tardio JasonBuy12.51K$0.799.88K
2025-06-05Neermann JoergBuy150.00K$0.77115.94K
2025-06-05Whaley GlennBuy503.00K$0.77388.77K
2025-06-05Nash DuaneBuy560.00K$0.77432.82K
2025-06-05PHILLIPS BARCLAY ABuy150.00K$0.77115.94K
2025-06-05Muehler AndreasBuy595.00K$0.77459.88K
2025-06-05Vitt DanielBuy1.53M$0.771.19M
2025-06-05Neermann JoergBuy30.00K$0.7622.80K
2025-06-04Vitt DanielBuy15.00K$0.7711.55K
2025-06-04Neermann JoergBuy70.00K$0.7753.90K
2025-06-03Whaley GlennBuy45.00K$0.7132.08K
2025-06-03Rudick Richard AlanBuy143.07K$0.70100.02K
2025-05-30Whaley GlennBuy25.00K$0.5614.00K
2024-12-04Nash DuaneBuy300.00K$1.25375.00K
2024-12-04Muehler AndreasBuy315.00K$1.25393.75K
2024-12-04Tardio JasonBuy157.50K$1.25196.88K
2024-12-04Vitt DanielBuy820.00K$1.251.02M
2024-12-04Whaley GlennBuy265.00K$1.25331.25K
2024-11-12Rudick Richard AlanBuy87.30K$1.15100.37K
2024-07-22Skerjanec SimonaBuy100.00K$1.46146.00K
2024-07-22Skerjanec SimonaBuy50.00K$1.4673.00K
2024-07-22Skerjanec SimonaOther0——
2024-07-12Tardio JasonBuy500.00K$1.25625.00K
2024-07-12Tardio JasonOther0——
2024-06-11Neermann JoergBuy100.00K$1.27127.00K
2024-06-11PHILLIPS BARCLAY ABuy100.00K$1.27127.00K
2024-06-11Rudick Richard AlanBuy100.00K$1.27127.00K
2024-06-11Toernsen Monika MariaBuy100.00K$1.27127.00K
2024-06-11HOWSON TAMAR DBuy100.00K$1.27127.00K
2024-03-04HOWSON TAMAR DBuy64.96K$1.72111.73K
2024-03-04HOWSON TAMAR DSell15.00K$12.30184.50K
2024-03-04HOWSON TAMAR DSell9.99K$9.5495.27K
2024-03-04HOWSON TAMAR DSell10.00K$14.77147.70K
2024-03-04HOWSON TAMAR DSell10.00K$3.4034.00K
2024-03-04Nash DuaneBuy379.96K$1.72653.53K
2024-03-04Nash DuaneSell90.00K$15.441.39M
2024-03-04Nash DuaneSell19.97K$13.63272.23K
2024-03-04Nash DuaneSell120.00K$17.002.04M
2024-03-04Nash DuaneSell75.00K$10.88816.00K
2024-03-04Nash DuaneSell10.00K$3.4034.00K
2024-03-04Nash DuaneSell30.00K$12.30369.00K
2024-03-04Nash DuaneSell10.00K$14.77147.70K
2024-03-04PHILLIPS BARCLAY ABuy64.96K$1.72111.73K
2024-03-04PHILLIPS BARCLAY ASell15.00K$12.30184.50K
2024-03-04PHILLIPS BARCLAY ASell10.00K$3.4034.00K
2024-03-04PHILLIPS BARCLAY ASell9.99K$7.6376.19K
2024-03-04PHILLIPS BARCLAY ASell10.00K$14.77147.70K
2024-03-04Vitt DanielBuy485.00K$1.72834.20K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 61, holders -19 vs prior quarter. Ownership 282.06%.

HolderSharesChangeChange %Value
ABERDEEN GROUP PLC824.39K-7.42M-90.00%12.67M
BVF INC/IL765.29K-6.89M-90.00%11.76M
MILLENNIUM MANAGEMENT LLC740.35K-3.04M-80.41%11.38M
AVIDITY PARTNERS MANAGEMENT LP669.94K-6.03M-90.00%10.30M
BRAIDWELL LP645.01K645.01KNew9.91M
LAURION CAPITAL MANAGEMENT LP610.33K-3.27M-84.28%9.38M
VANGUARD CAPITAL MANAGEMENT LLC571.56K-4.57M-88.88%8.78M
JONES HILL CAPITAL LP539.81K539.81KNew8.30M
WOODLINE PARTNERS LP471.53K-495.62K-51.25%7.25M
SOLEUS CAPITAL MANAGEMENT, L.P.450.00K-4.05M-90.00%6.92M
PROPEL BIO MANAGEMENT, LLC325.02K-2.02M-86.14%5.00M
NANTAHALA CAPITAL MANAGEMENT, LLC250.65K-2.26M-90.00%3.85M
UBS GROUP AG175.76K-347.04K-66.38%2.70M
GEODE CAPITAL MANAGEMENT, LLC170.68K-1.36M-88.81%2.62M
683 CAPITAL MANAGEMENT, LLC147.25K-2.30M-93.99%2.26M
ADAGE CAPITAL PARTNERS GP, L.L.C.139.86K-1.26M-90.00%2.15M
BLACKROCK, INC.132.79K-831.44K-86.23%2.04M
SUSQUEHANNA INTERNATIONAL GROUP, LLP118.40K97.70K+471.98%1.82M
MARSHALL WACE, LLP104.82K104.82KNew1.61M
SUSQUEHANNA INTERNATIONAL GROUP, LLP90.89K70.19K+339.08%1.40M
JANE STREET GROUP, LLC89.69K74.59K+493.95%1.38M
JEFFERIES FINANCIAL GROUP INC.84.90K84.90KNew1.30M
VANGUARD FIDUCIARY TRUST CO82.03K-658.51K-88.92%1.26M
IKARIAN CAPITAL, LLC67.46K-607.20K-90.00%1.04M
STATE STREET CORP61.26K-504.39K-89.17%941.55K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Immunic (IMUX) Stock Insights

IMUX$7.98+0.37 +4.86%

$108.88M

Market Cap

-1.54

P/E

5.28

Forward P/E

—

Score

Price History